Assembly Biosciences Company Profile (NASDAQ:ASMB)

About Assembly Biosciences

Assembly Biosciences logoAssembly Biosciences, Inc. is a biotechnology company. The Company is engaged in developing approximately two platform programs, such as a class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection, and a class of oral biological therapeutics, which are designed to restore health to a dysbiotic microbiome. It has discovered various core protein Allosteric Modulators (CpAMs), which are small molecules that directly target and allosterically modulate a number of Hemoglobin C functions. The Microbiome Program consists of an integrated platform that includes a strain identification and selection process, methods for strain isolation and growth under current good manufacturing practice (cGMP) conditions, and a delivery system, GEMICEL, which allows for targeted oral delivery of live biologic and conventional therapies to the lower gastrointestinal tract. The lead program from this platform, AB-M101, is in development for the treatment of C. difficile-infections.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: Pharmaceuticals
  • Exchange: NASDAQ
  • Symbol: ASMB
  • CUSIP: 92282210
Key Metrics:
  • Previous Close: $20.21
  • 50 Day Moving Average: $17.96
  • 200 Day Moving Average: $12.16
  • 52-Week Range: $4.33 - $21.39
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $346.05M
  • Outstanding Shares: 17,225,000
  • Beta: 0.27
Profitability:
  • Return on Equity: -38.29%
  • Return on Assets: -33.08%
Debt:
  • Current Ratio: 7.92%
  • Quick Ratio: 7.92%
Additional Links:
Companies Related to Assembly Biosciences:

Analyst Ratings

Consensus Ratings for Assembly Biosciences (NASDAQ:ASMB) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: N/A

Analysts' Ratings History for Assembly Biosciences (NASDAQ:ASMB)
Show:
DateFirmActionRatingPrice TargetDetails
8/19/2016William BlairInitiated CoverageMarket Perform -> OutperformView Rating Details
3/18/2015Cantor FitzgeraldReiterated RatingHold$6.50View Rating Details
(Data available from 2/23/2015 forward)

Earnings

Earnings History for Assembly Biosciences (NASDAQ:ASMB)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/21/2014($0.49)($1.33)ViewN/AView Earnings Details
4/2/2014($0.28)($0.29)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Assembly Biosciences (NASDAQ:ASMB)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20161($0.67)($0.67)($0.67)
Q4 20161($0.68)($0.68)($0.68)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Assembly Biosciences (NASDAQ:ASMB)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Assembly Biosciences (NASDAQ:ASMB)
Insider Ownership Percentage: 15.90%
Institutional Ownership Percentage: 64.82%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/11/2016Derek A. SmallCEOBuy10,000$5.53$55,300.00View SEC Filing  
5/27/2014Russell H EllisonCEOBuy13,000$0.92$11,960.00View SEC Filing  
5/23/2014David Jonathan BarrettCFOBuy6,980$0.86$6,002.80View SEC Filing  
5/23/2014Russell H EllisonCEOBuy20,000$0.91$18,200.00View SEC Filing  
5/21/2014Russell EllisonCEOBuy10,000$0.87$8,700.00View SEC Filing  
5/20/2014David Jonathan BarrettCFOBuy40,000$0.88$35,200.00View SEC Filing  
2/5/2013Russell H EllisonCEOBuy15,000$2.55$38,250.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Assembly Biosciences (NASDAQ:ASMB)
DateHeadline
finance.yahoo.com logoAssembly Biosciences Announces the Closing and Early Termination of Hart-Scott-Rodino Waiting Period for License of Microbiome Gastrointestinal Development Programs to Allergan (NASDAQ:ASMB)
finance.yahoo.com - February 21 at 9:10 AM
streetinsider.com logoAssembly Biosciences (ASMB) Completes Dose Ranging Portion of Phase 1a/1b Trial of ABI-H0731 (NASDAQ:ASMB)
www.streetinsider.com - February 17 at 6:29 PM
finance.yahoo.com logoAssembly Biosciences Announces Successful Completion of ABI-H0731 Phase 1a Trial and Upcoming Conference Presentations (NASDAQ:ASMB)
finance.yahoo.com - February 16 at 8:34 AM
finance.yahoo.com logoAssembly Biosciences (ASMB) Looks Good: Stock Up 13.9% (NASDAQ:ASMB)
finance.yahoo.com - January 18 at 4:18 PM
4-traders.com logoALLERGAN : TO PAY $15M PENALTY OVER MERGER (NASDAQ:ASMB)
www.4-traders.com - January 18 at 2:27 AM
News IconAssembly Biosciences Deal Worth at Least $50M (NASDAQ:ASMB)
www.insideindianabusiness.com - January 11 at 9:23 PM
marketexclusive.com logoassembly biosciences (NASDAQ:ASMB) Files An 8-K Entry into a Material Definitive Agreement (NASDAQ:ASMB)
marketexclusive.com - January 11 at 1:43 AM
biz.yahoo.com logoASSEMBLY BIOSCIENCES, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:ASMB)
us.rd.yahoo.com - January 10 at 8:43 PM
us.rd.yahoo.com logo8:11 am Assembly Biosciences enters into research, development, collaboration and license agreement with Allergan (AGN (NASDAQ:ASMB)
us.rd.yahoo.com - January 10 at 3:42 PM
biz.yahoo.com logoASSEMBLY BIOSCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, (NASDAQ:ASMB)
biz.yahoo.com - January 10 at 3:42 PM
4-traders.com logoWest Suffolk Forest Heath and St Edmundsbury Cou : Fuel poverty project makes ‘major difference’ to people’s lives (NASDAQ:ASMB)
www.4-traders.com - January 9 at 4:29 PM
streetinsider.com logoAllergan (AGN) Enters Licensing Agreement with Assembly Biosciences (ASMB) to Obtain Worldwide Rights to GI Programs (NASDAQ:ASMB)
www.streetinsider.com - January 9 at 4:29 PM
investopedia.com logoAGN Stock Is Preparing For Battle (AGN) (NASDAQ:ASMB)
www.investopedia.com - January 9 at 4:29 PM
News IconAssembly Biosciences Inc ASMB Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:ASMB)
www.bioportfolio.com - January 7 at 4:10 PM
insidermonkey.com logoIs Assembly Biosciences Inc (ASMB) A Good Stock To Buy According To Hedge Funds? (NASDAQ:ASMB)
www.insidermonkey.com - December 20 at 8:34 AM
biz.yahoo.com logoASSEMBLY BIOSCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Ex (NASDAQ:ASMB)
biz.yahoo.com - December 9 at 8:43 PM
biz.yahoo.com logoASSEMBLY BIOSCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:ASMB)
biz.yahoo.com - December 6 at 12:37 PM
capitalcube.com logoAssembly Biosciences, Inc. :ASMB-US: Earnings Analysis: Q3, 2016 By the Numbers : November 29, 2016 (NASDAQ:ASMB)
www.capitalcube.com - November 29 at 4:36 PM
News IconNew Market Report: Cellmid Limited (CDY) - Financial and Strategic SWOT Analysis Review (NASDAQ:ASMB)
reports.pr-inside.com - November 17 at 1:58 PM
News IconAssembly Biosciences, Inc. ASMB Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:ASMB)
www.bioportfolio.com - November 16 at 9:29 PM
finance.yahoo.com logoAssembly Biosciences to Present Data on ABI-H0731 at AASLD 2016 Liver Meeting (NASDAQ:ASMB)
finance.yahoo.com - November 11 at 12:59 PM
streetinsider.com logoAssembly Biosciences (ASMB) Commences ABI-H0731 Phase 1 as HBV Treatment (NASDAQ:ASMB)
www.streetinsider.com - November 10 at 2:05 PM
publicnow.com logoAssembly Biosciences Initiates Phase 1 Clinical Program of ABI-H0731 for Treatment of Chronic Hepatitis B Virus Infection (NASDAQ:ASMB)
www.publicnow.com - November 9 at 12:32 PM
zacks.com logoAssembly Biosciences (ASMB) Worth a Look: Stock Up 7.3% (NASDAQ:ASMB)
www.zacks.com - October 17 at 8:26 AM
4-traders.com logoBUYINS.NET: ASMB SqueezeTrigger Price is $11.20. There is $1,903,269 That Short Sellers Still Need To Cover. (NASDAQ:ASMB)
www.4-traders.com - October 14 at 3:34 PM
News IconBiotech Company Adds to Leadership Team (NASDAQ:ASMB)
www.insideindianabusiness.com - September 30 at 4:02 PM
publicnow.com logoAssembly Biosciences Announces Key Additions to Microbiome Team (NASDAQ:ASMB)
www.publicnow.com - September 28 at 8:24 AM
finance.yahoo.com logoAssembly Biosciences Announces Participation in HBV Scientific Meetings in China and South Korea (NASDAQ:ASMB)
finance.yahoo.com - September 21 at 8:31 AM
biz.yahoo.com logoASSEMBLY BIOSCIENCES, INC. Files SEC form 8-K, Other Events (NASDAQ:ASMB)
biz.yahoo.com - September 2 at 8:19 AM
fxpips.com logoREVIEW: Top Gainers, Losers in Manufacturing Sector (NASDAQ:ASMB)
www.fxpips.com - July 4 at 8:27 AM
kcregister.com logoDrug Most Volatile Stocks: Echo Therapeutics (NASDAQ:ECTE), Biostar Pharmaceuticals (NASDAQ:BSPM), Assembly ... - KC Register (NASDAQ:ASMB)
www.kcregister.com - June 30 at 11:28 AM
capitalcube.com logoAssembly Biosciences, Inc. :ASMB-US: Earnings Analysis: Q1, 2016 By the Numbers : June 8, 2016 (NASDAQ:ASMB)
www.capitalcube.com - June 8 at 6:04 PM
kcregister.com logoHealthcare Stocks in Focus: Tonix (NASDAQ:TNXP), Echo Therapeutics, (NASDAQ:ECTE), Assembly Biosciences ... - KC Register (NASDAQ:ASMB)
www.kcregister.com - June 7 at 11:31 AM
biz.yahoo.com logoASSEMBLY BIOSCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a (NASDAQ:ASMB)
biz.yahoo.com - June 6 at 4:02 PM
fxpips.com logoGaps Down Stocks - ASMB, KRNT, NSIT, WSCI, LE, APHB, DAKT - FxPips.com (NASDAQ:ASMB)
www.fxpips.com - June 1 at 9:43 PM
News IconAssembly Biosciences to Present at the Jefferies 2016 Global Healthcare Conference - PharmiWeb.com (press release) (NASDAQ:ASMB)
www.pharmiweb.com - June 1 at 3:39 PM
publicnow.com logoAssembly Biosciences to Present at the Jefferies 2016 Global Healthcare Conference (NASDAQ:ASMB)
www.publicnow.com - June 1 at 7:43 AM
fxpips.com logoGaps Up Stocks Daily Roundup - PRTO, FMD, ASMB, OCC, MARA, GASS, AGLE - FxPips.com (NASDAQ:ASMB)
www.fxpips.com - May 26 at 1:44 PM
publicnow.com logoAssembly Biosciences to Present Data at The International Liver Congress(TM) 2016 that Supports Advancing Its CpAM Candidates into HBV Clinical Trials (NASDAQ:ASMB)
www.publicnow.com - April 13 at 7:22 AM
publicnow.com logoAssembly Biosciences to Present Data on New Series of HBV Core Protein Allosteric Modifiers at The International Liver Congress™ 2016 (NASDAQ:ASMB)
www.publicnow.com - March 30 at 7:50 AM
biz.yahoo.com logoASSEMBLY BIOSCIENCES, INC. Files SEC form 10-K, Annual Report (NASDAQ:ASMB)
biz.yahoo.com - March 11 at 4:04 PM
News IconAssembly Biosciences Incorporated (NASDAQ:ASMB) Shorted Shares Increased By 8.41% - RiversideGazette.com (NASDAQ:ASMB)
www.riversidegazette.com - February 28 at 2:54 PM
globenewswire.com logoAssembly Biosciences to Webcast Upcoming Investor Conferences - GlobeNewswire (press release) (NASDAQ:ASMB)
globenewswire.com - February 19 at 2:59 PM
finance.yahoo.com logoAssembly Biosciences to Webcast Upcoming Investor Conferences (NASDAQ:ASMB)
finance.yahoo.com - February 19 at 7:30 AM
News IconAssembly Biosciences, Inc. (ASMB) Files Form 4 Insider Buying : Derek A Small Buys 10000 Shares - Los Angeles Mirror (NASDAQ:ASMB)
www.losangelesmirror.net - February 18 at 2:42 PM
News IconAssembly Biosciences Incorporated (NASDAQ:ASMB) Shorted Shares Increased By 1.18% - fdanewsalert.com (NASDAQ:ASMB)
www.fdanewsalert.com - February 12 at 2:03 PM
kcregister.com logoTrader's Recap: Travelport Worldwide Limited (NYSE:TVPT), Assembly Biosciences, Inc. (NASDAQ:ASMB), Neogen ... - KC Register (NASDAQ:ASMB)
www.kcregister.com - February 8 at 1:25 PM
News IconAssembly Biosciences Incorporated (NASDAQ:ASMB) Shorted Shares Increased By 19.64% - fdanewsalert.com (NASDAQ:ASMB)
www.fdanewsalert.com - February 6 at 2:00 PM
News IconLatest Alerts: SunEdison (NYSE:SUNE), Nokia Corporation (NYSE:NOK), Assembly Biosciences (NASDAQ:ASMB ... - Property Mentor (NASDAQ:ASMB)
www.propertymentorgroup.com - February 2 at 12:43 PM
News IconCompany Shares of Assembly Biosciences, Inc. (NASDAQ:ASMB) Drops by -11.11% - Bull Report (NASDAQ:ASMB)
www.bullreport.news - February 1 at 12:25 PM

Social

What is Assembly Biosciences' stock symbol?

Assembly Biosciences trades on the NASDAQ under the ticker symbol "ASMB."

Who owns Assembly Biosciences stock?

Assembly Biosciences' stock is owned by a variety of of retail and institutional investors. Top institutional investors include EcoR1 Capital LLC (17.09%), Orbimed Advisors LLC (8.11%), Perceptive Advisors LLC (4.15%) and Dimensional Fund Advisors LP (0.27%).

Who bought Assembly Biosciences stock? Who is buying Assembly Biosciences stock?

Assembly Biosciences' stock was acquired by a variety of institutional investors in the last quarter, including Perceptive Advisors LLC and Dimensional Fund Advisors LP.

How do I buy Assembly Biosciences stock?

Shares of Assembly Biosciences can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Assembly Biosciences stock cost?

One share of Assembly Biosciences stock can currently be purchased for approximately $20.09.

Assembly Biosciences (NASDAQ:ASMB) Chart for Thursday, February, 23, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Assembly Biosciences (NASDAQ:ASMB)

Earnings History Chart

Earnings by Quarter for Assembly Biosciences (NASDAQ:ASMB)

Dividend History Chart

Dividend Payments by Quarter for Assembly Biosciences (NASDAQ:ASMB)

Last Updated on 2/23/2017 by MarketBeat.com Staff